Larry Norton

The titles of Dr. Larry Norton, M.D. include, at Memorial Sloan Kettering, the Norna S. Sarofim Chair of Clinical Oncology, Senior Vice President in the Office of the President, Medical Director of the Evelyn H. Lauder Breast Center, and Deputy Director for Clinical and Translational Science of the NCI Cancer Center. He is also Professor of Medicine, Weill-Cornell Medical College and has adjunct appointments at the Cold Spring Harbor Laboratory and the Sloan School of Management, Massachusetts Institute of Technology. He is a co-founder in 1993 with Evelyn H. Lauder of the Breast Cancer Research Foundation and is now it’s Founding Scientific Director. Dr. Norton has served on or chaired numerous committees of the National Cancer Institute, National Institutes of Health, and the Institute of Medicine of the National Academy of Sciences and has served as President of the American Society of Clinical Oncology among other leadership roles in that and other organizations. He is also a Fellow of the American Society of Clinical Oncology, the American Association for Cancer Research Academy, and the American Academy of Arts and Sciences.

Dr. Norton has dedicated his life to the eradication of cancer by activities in medical care, laboratory and clinical research, advocacy and government. His research is broad, but he is best known for mathematical modeling in therapeutic development. He has been involved in the development of several effective agents including paclitaxel and trastuzumab. He co-invented the Norton-Simon Model of cancer growth, which has broadly influenced cancer therapy, and more recently the self-seeding concept of cancer metastasis and growth. He is an author of more than 400 published articles and many book chapters.

Among many honors, he received ASCO’s Karnofsky and Bonadonna Awards, the McGuire Lectureship at the San Antonio Breast Cancer Symposium, MSKCC’s Whitmore Award for Clinical Excellence, the Columbia University’s Gold Medal for Outstanding Achievement in Medical Research, The Cold Spring Harbor Laboratory Double Helix Award as well as the Thomson Reuters Highly Cited Researcher Certificate.